Idenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Leveraging its expertise in nucleoside chemistry and other small molecule chemistry and biology, Idenix currently focuses on the treatment of patients with hepatitis C infection. The company also co-developed and co-launched telbivudine for the treatment of hepatitis B. For more information visit the company’s Web site at www.idenix.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: